This reporting standards document has been created in two parts. Part One summarized existing multinational governmental and nongovernmental guidelines and regulations for reporting adverse events that occur with the use of medical devices for peripheral vascular interventions. 1 Other important components required for the safe and proper conduct of a clinical trial evaluating vascular devices were also summarized. The aim of the current document is the same: to achieve greater reporting consistency between clinicians, investigators, specialties, institutions, and investigational studies. In Part Two, the reporting of adverse events is organized by disease process. Formal guidelines were not specified in Part One and definitions were in large part general. Rather than the general suggestions and definitions included in Part One, the recommendations in Part Two are broadly grouped by vascular disease system: arterial and venous. Within each system, recommendations are included specific to an individual disease process, for example, carotid stenosis, aortic aneurysms, and lower extremity occlusive disease.